You are here

Article info

Article menu

Download PDFPDF

Review
The role of NDRG1 in the pathology and potential treatment of human cancers
Free

Authors

  • Dong-Hun Bae Molecular Pharmacology and Pathology Program, Department of Pathology and Bosch Institute, University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Patric J Jansson Molecular Pharmacology and Pathology Program, Department of Pathology and Bosch Institute, University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Michael L Huang Molecular Pharmacology and Pathology Program, Department of Pathology and Bosch Institute, University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Zaklina Kovacevic Molecular Pharmacology and Pathology Program, Department of Pathology and Bosch Institute, University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Danuta Kalinowski Molecular Pharmacology and Pathology Program, Department of Pathology and Bosch Institute, University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • C Soon Lee Discipline of Pathology, and Molecular Medicine Research Group, School of Medicine, University of Western Sydney, Sydney, New South Wales, Australia Cancer Pathology Bosch Institute, University of Sydney, Sydney, New South Wales, Australia Cancer Pathology & Cell Biology Laboratory, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Sumit Sahni Molecular Pharmacology and Pathology Program, Department of Pathology and Bosch Institute, University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Des R Richardson Molecular Pharmacology and Pathology Program, Department of Pathology and Bosch Institute, University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Sumit Sahni or Prof Des R Richardson, Molecular Pharmacology and Pathology Program, Department of Pathology and Bosch Institute, University of Sydney, Blackburn Building (D06), Sydney, New South Wales 2006, Australia; sumit.sahni{at}sydney.edu.au or d.richardson{at}sydney.edu.au
View Full Text

Citation

Bae D, Jansson PJ, Huang ML, et al
The role of NDRG1 in the pathology and potential treatment of human cancers
Journal of Clinical Pathology 2013;66:911-917.

Publication history

  • Received May 14, 2013
  • Accepted May 15, 2013
  • First published June 8, 2013.
Online issue publication 
October 31, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions